Litigation Details for AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
✉ Email this page to a colleague
AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-10-30 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-05 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934 | ||
Firms | Phillips, McLaughlin & Hall, P.A. | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca LP v. Mylan Pharmaceuticals Inc.
Details for AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-02-07 | 30 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419…2015 6 February 2018 1:15-cv-00999 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |